FDA Inspection
Stephen G. Thein, Ph.D.Stephen G. Thein, Ph.D. – FDA Inspection, Apr 25, 2025
Record Details
This FDA Inspection record concerns Stephen G. Thein, Ph.D., with an inspection on April 25, 2025, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · b6f0ce01-f6f3-45c7-a3c1-94f0ac2ecfbd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1267928
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.66Changes in research
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Stephen G. Thein, Ph.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 18, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 3, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Stephen G. Thein, Ph.D.
- FDA Inspection 1144715 - 2021-06-18
- FDA Inspection 1061370 - 2018-08-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.